Clinical trial · Observational
Circulating Tumor Cells (CTCs) in Advanced Gastric Cancer
Prediction of Recurrence in Advanced Gastric Cancer After Radical Resection by Circulating Tumor Cells （CTCs）
NCT01848015CI-TRIAL-00017951unknownClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
To assess the predictive value of circulating tumor cells (CTCs) for recurrence of advanced gastric cancer after radical resection. To identify the relationship between the detection of circulation tumor cells and recurrence patterns of gastric cancer after radical resection.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Gastric Cancer | Malignant Gastric Neoplasm | CURATED_BROADER | 0.80 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| detection of CTCs | Other | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- label
- CTCs positive
- interventionNames
- Other: detection of CTCs
Primary outcomes (1)
- measure
- CTCs
- timeFrame
- 2 months
Secondary outcomes (1)
- measure
- Recurrence of gastric cancer after radical resection
- timeFrame
- 2 years
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
- Maximum age
- 75 Years
Show eligibility criteria text
Inclusion Criteria: * Having signed informed consent * Age≥ 18 years old * Histologically confirmed gastric adenocarcinoma * Preoperative clinical examination and imaging indicating operable disease * complete resection (R0 resection) * D2 or D2+ resection Exclusion Criteria: * Other tumor type than adenocarcinoma * Patients who have been given preoperative chemotherapy/chemoradiation. * Staging investigations or intraoperative exploration indicating inoperable disease * R1 or R2 resection * D0 or D1 resection * Patients unreliable for follow up * Past history of malignancy
References
Publications (1)
- DERIVEDZhang Q, Shan F, Li Z, Gao J, Li Y, Shen L, Ji J, Lu M. A prospective study on the changes and clinical significance of pre-operative and post-operative circulating tumor cells in resectable gastric cancer. J Transl Med. 2018 Jun 20;16(1):171. doi: 10.1186/s12967-018-1544-1. PMID 29925382